Latest News for Orion Stock (OTC:ORINY)

ORION OYJ ADR

Orion Oyj is a globally operating Finnish pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company predominantly focuses on treatments for central nervous system disorders, oncology, and respiratory diseases. Orion's customers include specialists and general practitioners, veterinarians, pharmacies, hospitals, and laboratories. Orion mainly serves Finland but also has a presence in other European countries, North America and other countries.

ORION CORP NEW UNSP/ADR by Orion Corporation OY

Orion Oyj

Orion Oyj is a globally operating Finnish pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients.

Stock Analysis: Orion Oyj

Marinus gets EU approval for anti-seizure treatment Ztalmy

Over the past year, Orion's share price dropped about 5.5% from $20.11 to $19.00 as of Tuesday's market close.